Sweden· SE-20171228000050
Methenamine hippurate EQL Pharma 1 g Tablett
A medicinal product containing methenamine hippurate, registered in Sweden by EQL Pharma AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Methenamine Hippurate
- Manufacturer
- EQL Pharma AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20171228000050
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methenamine hippurate in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMethenamine hippurateViona Pharmaceuticals Inc
- FinlandHiprexParanova Oy
- NorwayHiprexViatris AS
- IrelandMethenamine hippurate Brown & Burk 1 g tabletsBrown & Burk IR Limited
- GermanyCystohippDr. Pfleger Arzneimittel Gmbh
- BelgiumVesaphir 1 gGoodlife Specialty
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Vesaphir
- Germany · Cystohipp
- Denmark · Haiprex, Methenamine Hippurate Eql Pharma
- Finland · Hiprex, Methenamine Hippurate Orion
- France · Altaromin
- United Kingdom (Northern Ireland) · Hiprex, Methenamine Hippurate Brown & Burk Uk
- Ireland · Methenamine Hippurate Brown & Burk
- Iceland · Haiprex
- Luxembourg · Vesaphir
- Malta · Methenamine Hippurate Brown & Burk, Methenamine Hippurate Eql Pharma
- Netherlands · Vesaphir
- Norway · Hiprex, Methenamine Hippurate Eql Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c30dfbbc-8d03-47ea-862c-d102847f4ac2 GET /v1/drugs/c30dfbbc-8d03-47ea-862c-d102847f4ac2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20171228000050",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20171228000050",
"product_doc_link": "https://docetp.mpa.se/LMF/Methenamine%20hippurate%20EQL%20Pharma%20tablet%20SmPC_09001bee807a4e66.pdf"
}See everything about methenamine hippurate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.